KT-MS, 'Super Cooperation' to Improve Korea's AI Capabilities... "Providing AI Education to All Citizens" (Comprehensive)

KT and Microsoft (MS) are going beyond corporate partnerships to engage in hyper-collaboration to enhance Korea's artificial intelligence (A)I capabilities. The plan is to provide AI education to all citizens interested in AI and contribute to improving the level of "national AI literacy" (the ability to understand and utilize AI technology).



KT CEO Kim Young-seop (left) and Microsoft CEO and Chairman of the Board Satya Nadella pose for a commemorative photo after meeting at KT's Gwanghwamun office on the 25th. [Photo = KT]



First official meeting of the two companies' CEOs in Korea···Discussion of plans to promote AX in Korea



On the 26th, KT announced that KT CEO Kim Young-seop and Microsoft CEO and Chairman of the Board Satya Nadella met and exchanged opinions on accelerating the industry's AX (AI transition). The explanation is that they discussed agenda items that will help strengthen the country's AI competitiveness, such as the partnership between the two companies as well as the AI ​​Skilling Initiative (leading AI education).



CEO Kim Young-seop said, "The development of AX solutions based on strategic partnerships with MS, including Korean AI and KT SPC, is becoming visible," and added, "As an AX accelerator, we will become a strong partner to companies that need AX and expand the AX ecosystem in Korea."



CEO Satya Nadella arrived at Seoul Airport on the 25th and met with Amorepacific Chairman Suh Kyung-bae, CEO Kim Young-seop, and HD Hyundai Senior Vice Chairman Chung Ki-sun in succession. This is the first time in two years that a MS CEO has visited Korea. It has been reported that CEO Kim and CEO Nadella also exchanged opinions on the advancement of Korean AI models and public sector advancement through secure public clouds.



MS CEO Visits Korea, AI Tour Held⋯KT Operates Two Booths and Exhibition Halls



CEO Satya Nadella's official purpose of visiting Korea is to participate in the 'AI Tour in Seoul' (AI Tour). Through this event, MS unveiled two AI agents that applied the reasoning model to MS 365 Copilot for the first time in the world. The AI ​​Tour is an AI event hosted by MS in Korea, which opened this morning at the Yangjae aT Center in Seoul.



KT, which signed a strategic partnership with MS in September of last year, also attended the event. KT disclosed the progress made since signing the partnership with MS. The KT exhibition hall, which consists of two booths in the AI ​​Tour Premium Partner Zone, is representative.



The exhibits include six items: △GPT-4o-based custom model △Public cloud KT SPC (KT Secure Public Cloud) △'Carbon Emissions Management Assistant' for automating carbon emission calculation △'GPUaaS' that allocates cloud resources as needed △MS Copilot-based business innovation case △AI agent Works AI.



Satya Nadella, CEO and Chairman of the Board of Microsoft, is giving a keynote speech at the Microsoft AI Tour in Seoul held on the 26th. [Photo = KT]



MS CEO AI Tour Keynote Speech⋯"Promoting AI Skilling Initiative with KT"



On this day, CEO Satya Nadella announced in his AI Tour keynote speech that he would promote a nationwide AI skilling initiative with KT. The two companies have been forming a consensus on the need to establish AI education centers and provide specialized education curricula.



CEO Satya Nadella cited internal innovation, solution development, and Go-To-Market (GTM) as major achievements of collaboration with KT. KT plans to launch the AX Delivery Center (tentative name), an elite organization in the AX business within the company, and promote AX innovation in Korea in cooperation with MS experts. KT plans



to hold the AX Leader Summit periodically with the goal of expanding the domestic AX ecosystem. KT said, "We want to create a place for free communication between companies that want to share their experiences of innovation and transplant AX DNA into Korea."





https://www.inews24.com/view/blogger/1827342

Comments

Post a Comment

Popular posts from this blog

Livestock Manure Methane Is Soaring, But ‘Resource Recovery’ Isn’t Working [Now is a Climate Crisis]

Image
It has been pointed out that the methane emissions from the livestock waste treatment process were actually reported to be 2.5 times smaller than the previous calculation standards. It is expected that livestock waste will increase rapidly in the future, but an analysis report has been released that 'biogasification', which turns it into a resource, is only at the 10% level. It is urgent to come up with countermeasures as methane, one of the greenhouse gases, is expected to increase rapidly. According to the analysis of the entire livestock waste treatment process for the first time in Korea, the largest source of methane emissions was pigs (73%), and only 14% of pig waste was used for biogas in the public sector. It has been pointed out that it is urgent to come up with countermeasures as methane from livestock waste is increasing rapidly but 'resource conversion' is insufficient. [Photo = Climate Solution] About half of domestic methane...
Read more

After 2030, more powerful anticancer drugs will be available [Science Now]

Image
Postgraduate researcher Jiwoo Choi (first author) is using a pipette tool to transfer blood components into several wells (small containers) to culture them into macrophages [Photo = KRIST] A domestic research team has found a clue to a new anticancer technology that can complement the existing CAR-T anticancer drug. Dr. Jihoon Park's team at the Korea Research Institute of Chemical Technology (President Youngguk Lee) successfully produced CAR-M (Car-M, Car-Macrophage) by stably inserting anticancer genes into macrophages derived from human peripheral blood using lentivirus. It is expected to be applied to the treatment of solid cancers in addition to blood cancers. 'Chimeric antigen receptor (CAR) T cell therapy' is a technology that extracts T cells, which are immune cells, from the body, genetically modifies them to attack specific cancer cells, and then injects them into the patient. It is very effective in treating some blood cancers such as leukemia, b...
Read more